Contraindications for patients with serpatinib

Selpercatinib (Selpercatinib) is a targeted therapy commonly used to treat cancers with RET gene mutations, such as medullary thyroid cancer ( MTC), non-small cell lung cancer (NSCLC) and papillary thyroid cancer (PTC), etc. Although Selpatinib has shown significant efficacy in many patients, there are still situations where patients need to be extra careful when using this drug, because in some cases Selpatinib may have adverse reactions or interact with other drugs, causing the patient's health to further deteriorate. Therefore, the following are some patient contraindications for septinib (serpatinib):

1. Allergic reaction

An allergic reaction toseptinib or similar drugs is one of the contraindications to the use of this drug. Patients should avoid using septinib if they are allergic to any of the ingredients in the drug. Anaphylaxis may include symptoms such as skin rash, hives, difficulty breathing, and severe anaphylactic shock.

2. Severe liver damage

The use of serpotinib has been associated with abnormal liver function. Serpatinib should be avoided in patients with severe hepatic impairment, such as liver failure or in patients with liver damage that significantly affects pre-treatment liver function tests. The patient's liver function should be regularly tested before starting treatment and regularly monitored during treatment.

3. Heart problems

The use of serpotinib has been associated with cardiotoxicity. Patients with serious heart problems, such as heart failure, arrhythmia, etc., should avoid using this drug. Patients should undergo an electrocardiogram and cardiac ultrasound to assess heart function before starting treatment and monitor heart function regularly during treatment.

4. Drug interactions

Serpatinib may interact with other drugs, affecting their efficacy or increasing the risk of adverse reactions. Therefore, before starting treatment with septinib, patients should tell their doctor about all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Your doctor will evaluate drug interactions and adjust your dosage or choose an alternative drug as needed.

5. Pregnancy and lactation

Serputinib may cause damage to the fetus, so pregnant women should avoid using this drug. During use of septinib (serpatinib), female patients should take effective contraceptive measures to avoid pregnancy. In addition, female patients should stop breastfeeding during treatment with septinib because the drug may be passed to the infant through breast milk and have adverse effects on the infant.

Serpatinib As a targeted therapy drug, although it has shown significant efficacy in treating patients with some cancer types, there are still some contraindications that patients need to pay attention to. Patients should fully discuss and evaluate with their doctors before using Selpatinib to ensure the safety and effectiveness of the drug and to avoid the occurrence of potential adverse reactions or drug interactions